Jon J. Vernon

Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes

Jane Freeman, Jon J. Vernon, K. Morris et al. · Clinical Microbiology and Infection · 2014 · 264 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Antibiotics +9

The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014

Jane Freeman, Jon J. Vernon, Sally Pilling et al. · Clinical Microbiology and Infection · 2017 · 134 citations

Antimicrobial Susceptibility, Antibiotics, Medicine +8

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018

Virginie Viprey, Georgina Davis, Anthony Benson et al. · Eurosurveillance · 2022 · 49 citations · Full text

<i>In vitro</i> susceptibility of <i>Clostridium difficile</i> to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against <i>C. difficile</i>

David F. Corbett, Andrew K. Wise, Stephen Birchall et al. · Journal of Antimicrobial Chemotherapy · 2015 · 40 citations · Full text

Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2

Jon J. Vernon, Emma Black, Thomas Dennis et al. · Journal of Dental Research · 2021 · 35 citations · Full text